Abstract
OBJECTIVE: To investigate whether the Agouti-related protein (Agrp), the melanocortin receptor antagonist, alters oxygen consumption, as a measure of energy expenditure.
DESIGN: A 7-day intracerebroventricular administration of Agrp (1 nmol/day) in rats.
MEASUREMENTS: Oxygen consumption was determined in closed-circuit respirometers on days 1 and 8. BRL-35135, a β3-adrenoreceptor agonist known to activate the brown adipose tissue (BAT) thermogenesis directly and increase core temperature, was administered i.p. (40 μg/kg) on day 9 to challenge functionally the BAT.
RESULTS: Agrp treatment caused a 54% increase in daily food intake and a 12% increase in body weight. An 8% decrease in VO2 measurements was observed following ICV Agrp treatment on day 1. A similar decrease (7%) was observed on day 8. BRL-35135 stimulated colonic temperature in control rats. However, in the rats that had previously been treated with Agrp this effect was significantly blunted.
CONCLUSION: Chronic CNS administration of Agrp decreases oxygen consumption and decreases the capacity of BAT to expend energy. The obesity observed following CNS administration of Agrp is the result of decreased energy expenditure and increased food intake.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barsh G . From Agouti to Pomc — 100 years of fat blonde mice. Nat Med 1999; 5: 984–985.
Rossi M, Kim MS, Morgan DG, Small CJ, Edwards CM, Sunter D, Abusnana S, Goldstone AP, Russell SH, Stanley SA, Smith DM, Yagaloff K, Ghatei MA, Bloom SR . A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 1998; 139: 4428–4431.
Kask A, Rago L, Wikberg JE, Schioth HB . Evidence for involvement of the melanocortin MC4 receptor in the effects of leptin on food intake and body weight. Eur J Pharmacol 1998; 360: 15–19.
Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD . Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997; 385: 165–168.
Skuladottir GV, Jonsson L, Skarphedinsson JO, Mutulis F, Muceniece R, Raine A, Mutule I, Helgason J, Prusis P, Wikberg JE, Schioth HB . Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist. Br J Pharmacol 1999; 126: 27–34.
Raposinho PD, Castillo E, D'Alleves V, Broqua P, Pralong FP, Aulbert ML . Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes. Endocrinology 2000; 141: 4419–4427.
Satoh N, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Yoshimasa Y, Nakao K . Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett 1998; 249: 107–110.
Hwa JJ, Ghibaudi L, Gao J, Parker EM . Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats. Am J Physiol Regul Integr Comp Physiol 2001; 281: R444–R451.
Jonsson L, Skarphedinsson JO, Skuladottir GV, Atlason PT, Eiriksdottir VH, Franzson L, Schioth HB . Melanocortin receptor agonist transiently increases oxygen consumption in rats. Neuroreport 2001; 12: 3703–3708.
Fekete C, Legradi G, Mihaly E, Tatro JB, Rand WM, Lechan RM . alpha-Melanocyte stimulating hormone prevents fasting-induced suppression of corticotropin-releasing hormone gene expression in the rat hypothalamic paraventricular nucleus. Neurosci Lett 2000; 289: 152–156.
Kim MS, Small CJ, Stanley SA, Morgan DG, Seal LJ, Kong WM, Edwards CM, Abusnana S, Sunter D, Ghatei MA, Bloom SR . The central melanocortin system affects the hypothalamo–pituitary–thyroid axis and may mediate the effect of leptin. J Clin Invest 2001; 105: 1005–1011.
Small CJ, Kim MS, Stanley SA, Mitchell JR, Murphy K, Morgan DG, Ghatei MA, Bloom SR . Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. Diabetes 2001; 50: 248–254.
Meeran K, O'Shea D, Edwards CM, Turton MD, Heath MM, Gunn I, Abusnana S, Rossi M, Small CJ, Goldstone AP, Taylor GM, Sunter D, Steere J, Choi SJ, Ghatei MA, Bloom SR . Repeated intracerebroventricular administration of glucagon-like peptide-1 -(7–36) amide or exendin -(9–39) alters body weight in the rat. Endocrinology 1999; 140: 244–250.
Connoley IP, Liu YL, Frost I, Reckless IP, Heal DJ, Stock MJ . Thermogenic effects of sibutramine and its metabolites. Br J Pharmacol 1999; 126: 1487–1495.
Liu YL, Stock MJ . Acute administration of the beta3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation. Br J Pharmacol. 1995; 114: 888–894.
Stock MJ . An automatic, closed-circuit oxygen consumption apparatus for small animals. J Appl Physiol 1975; 39: 849–850.
Wang T, Hartzell DL, Rose BS, Flatt WP, Hulsey MG, Menon NK, Makula RA, Baile CA . Metabolic responses to intracerebroventricular leptin and restricted feeding. Physiol Behav. 1999; 65: 839–848.
Overton JM, Williams TD, Chambers JB, Rashotte ME . Chronic leptin infusion attenuates the cardiovascular and metabolic effects of fasting in rats. Hypertension 2001; 37: 663–669.
Griggio MA, Luz J, Carvalho SM . The effect of fasting and refeeding on oxygen consumption by rats. Braz J Med Biol Res 1992; 25: 205–208.
Bing C, Hopkins D, Wang Q, Frankish H, Buckingham R, Williams G . Direct stimulation of BAT thermogenesis does not affect hypothalamic neuropeptide Y. Peptides 1998; 19: 167–170.
Murgatroyd PR, Shetty PS, Prentice AM . Techniques for measurement of human energy expenditure: a practical guide. Int J Obes Relat Metab Disord 1993 Oct; 17(10): 549–568.
Acknowledgements
This work is funded by a Medical Council Research (MRC) programme grant (SR Bloom, MA Ghatei, CJ Small, G7811974). This work was conducted as a collaborative research project. The authors acknowledge Professor Stock for his input into this work and for his expert guidance. We dedicate this manuscript to him.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Small, C., Liu, Y., Stanley, S. et al. Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditure. Int J Obes 27, 530–533 (2003). https://doi.org/10.1038/sj.ijo.0802253
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802253
Keywords
This article is cited by
-
Aberrant expression of agouti signaling protein (ASIP) as a cause of monogenic severe childhood obesity
Nature Metabolism (2022)
-
Deciphering an AgRP-serotoninergic neural circuit in distinct control of energy metabolism from feeding
Nature Communications (2021)
-
Unravelling the mysterious roles of melanocortin-3 receptors in metabolic homeostasis and obesity using mouse genetics
International Journal of Obesity Supplements (2014)
-
Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus
Gene Therapy (2013)
-
Melanocortin receptor-mediated effects on obesity are distributed over specific hypothalamic regions
International Journal of Obesity (2011)